Evidence map›Paper›PMID 35860730›Full record

ArticleFrontiers in medicine2022

Prevalence of Chronic Infection by Hepatitis C Virus in Asymptomatic Population With Risk Factors in Cartagena, Colombia.

Pedro Imbeth-Acosta, Víctor Leal-Martínez, Enrique Ramos-Clason, Nehomar Pájaro-Galvis, María Cristina Martínez-Ávila, Amilkar Almanza-Hurtado, Tomás Rodríguez-Yanez, Jorge Bermudez-Montero, Oscar Vergara-Serpa, Emilio Abuabara-Franco and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Pedro Imbeth-AcostaDepartment of Gastroenterology and Hepatology, Diagnostico y Terapeutica en Gastroenterologia y Hepatologia (DITEG), Cartagena, Colombia.
Víctor Leal-MartínezDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
Enrique Ramos-ClasonDepartment of Public Health and Medical Research, University of Sinu, Cartagena, Colombia.
Nehomar Pájaro-GalvisDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
María Cristina Martínez-ÁvilaEpidemiologist, Grupo Biotoxam, Universidad de Cartagena, Cartagena, Colombia.
Amilkar Almanza-HurtadoDepartment of Critical Care Médicine, Gestion Salud Instituto Prestador de Salud (IPS), University of Cartagena, Cartagena, Colombia.
Tomás Rodríguez-YanezDepartment of Critical Care Médicine, Gestion Salud Instituto Prestador de Salud (IPS), University of Cartagena, Cartagena, Colombia.
Jorge Bermudez-MonteroDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
Oscar Vergara-SerpaDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
Emilio Abuabara-FrancoDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
María Raad-SarabiaDepartment of Internal Medicine, University of Sinu, Cartagena, Colombia.
Erika Patricia Villar-GonzálezUniversity of Sinu, Cartagena, Colombia.
Steffany Isabel Tatis-GeneyDepartment of Family Medicine, Hospital San Vicente Fundación, Medellín, Colombia.
Luis Adolfo Collazos-TorresUniversity of Sucre, Sincelejo, Colombia.
Jorge Rico-FontalvoDepartment of Nephrology, Colombian Association of Nephrology, Medellín, Colombia.
Rodrigo Daza-ArnedoDepartment of Nephrology, Colombian Association of Nephrology, Medellín, Colombia.
Christian Pérez-CalvoDepartment of Internal Medicine, Libre University, Barranquilla, Colombia.
Huber Alvarado-CastellUniversity of Cartagena, Cartagena, Colombia.
Gabriel Hernando López AcuñaSanitas University, Bogotá, Colombia.
Universidad del Sinú · COUniversity of Cartagena · COColombian Association of Surgery · COFundación Universitaria Sanitas · COHospital Universitario de San Vicente Fundación · COUniversidad Libre de Colombia · COUniversity of Sucre · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Infection by the hepatitis C virus (HCV) is an important cause of chronic liver disease, considered a public health problem worldwide with high morbidity and mortality due to limited access to diagnostic tests in developing countries. Only a small percentage know their infection status and receive timely treatment. It is critical to make diagnostic tests for HCV infection accessible and to provide timely treatment, which not only reduces the spread of infection but also stops the progression of HCV disease without symptoms. Objective: To determine the prevalence of chronic infection by HCV in patients with risk factors by using rapid tests in Cartagena, Colombia, and describe their epidemiological characteristics. Methodology: A cross-sectional descriptive observational study was carried out on asymptomatic adults with risk factors for HCV infection in the city of Cartagena between December 2017 and November 2019. A rapid immunochromatographic test was performed to detect antibodies, characterizing the population. Results: In total, 1,023 patients were identified who met the inclusion criteria, 58.5% women and 41.4% men, obtaining nine positive results, confirming chronic infection with viral load for HCV, finding seven cases of genotype 1b and two genotype 1a. Conclusion: In our study, a prevalence of hepatitis C infection of 0.9% was found in asymptomatic individuals with risk factors, which allows us to deduce that the active search for cases in risk groups constitutes a pillar for the identification of the disease, the initiation of antiviral therapy, and decreased morbidity and mortality.

Indexed as

adultsasymptomaticchronichepatitis Cprevalencerapid diagnostic test

Identifiers

PMID35860730
PMCPMC9289182
OpenAlexW4283803332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.